Alternative routes of influenza vaccine delivery.
The global emergence of virulent avian influenza and the concomitant raised threat of an influenza pandemic has increased interest in the development of improved influenza vaccines. Whereas conventional influenza vaccines are delivered by parenteral injection, an intranasal influenza vaccine has been marketed since 2003. Many other technologies are in development for intranasal, oral, epidermal and topical influenza vaccines. This editorial summarises the advances in clinical development of technologies for needle-free influenza vaccine delivery.
Dean
Hansi J
HJ
D000281:Administration, Intranasal; D000284:Administration, Oral; D000287:Administration, Topical; D006801:Humans; D007252:Influenza Vaccines / Q000008:administration & dosage*
D007252:Influenza Vaccines